StonvexLoading…
StonvexStonvexStonvexCore line items from COST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-08-31 | Annual 2024 2024-09-01 | Annual 2023 2023-09-03 | Annual 2022 2022-08-28 |
|---|---|---|---|---|
Revenue | $275.24B | $254.45B | $242.29B | $226.95B |
Operating Income | $10.38B | $9.29B | $8.11B | $7.79B |
Net Income | $8.10B | $7.37B | $6.29B | $5.84B |
EPS (Diluted) | $18.21 | $16.56 | $14.16 | $13.14 |
Total Assets | $77.10B | $69.83B | $68.99B | $64.17B |
Total Liabilities | $47.94B | $46.21B | $43.94B | $43.52B |
Cash & Equivalents | $14.16B | $9.91B | $13.70B | $10.20B |
Free Cash Flow OCF − CapEx | $7.84B | $6.63B | $6.75B | $3.50B |
Shares Outstanding | 443.24M | 443.13M | 442.79M | 442.66M |